CNWM
ALAB icon

Clay Northam Wealth Management’s Astera Labs ALAB Stock Holding History

Clay Northam Wealth Management’s Portfolio ALAB Stock Details ALAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$461K Buy
4,203
+355
+9% +$50.6K 0.26% 62
2025
Q4 		$640K Buy
3,848
+663
+21% +$111K 0.36% 44
2025
Q3 		$624K Buy
3,185
+590
+23% +$97K 0.36% 44
2025
Q2 		$235K Buy
+2,595
New +$205K 0.15% 76

Other funds holding ALAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
AM
Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Clay Northam Wealth Management's ALAB Position: Q1 2026 in Review

Clay Northam Wealth Management increased its Astera Labs (ALAB) stake by 9.2% in Q1 2026, buying an estimated $50.6K and bringing the position to 4,203 shares worth $461K. The position accounts for 0.26% of the portfolio, ranked #62.

Clay Northam Wealth Management first reported a position in ALAB in Q2 2025 and has held it in 4 quarters since. The position peaked at $640K in Q4 2025. 703 funds tracked by Wall St. Rank hold ALAB as of Q1 2026.

  • Clay Northam Wealth Management held 4,203 shares of Astera Labs worth $461K as of Q1 2026.
  • Clay Northam Wealth Management bought 355 Astera Labs shares in Q1 2026, an estimated $50.6K.
  • Astera Labs made up 0.26% of Clay Northam Wealth Management's portfolio in Q1 2026, its #62 holding.
  • Clay Northam Wealth Management first reported a position in Astera Labs in Q2 2025 and has held it in 4 quarters since.
  • Clay Northam Wealth Management's Astera Labs position peaked at $640K in Q4 2025.
  • 703 funds tracked by Wall St. Rank held Astera Labs as of Q1 2026.

Based on Clay Northam Wealth Management's 13F filing for Q1 2026, filed 28 Apr 2026.